Anemia management and the delay of chronic renal failure progression

被引：35

作者：

Rossert, J

Fouqueray, B

Boffa, JJ

机构：

[1] Univ Paris 06, Dept Nephrol, Hop Tenon, F-75020 Paris, France

[2] INSERM, U489, Paris, France

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷 / 07期

关键词：

D O I：

10.1097/01.ASN.0000070079.54912.B6

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Interstitial fibrosis plays a key role in the progression of chronic kidney diseases. Analysis of the biologic effects of erythropoietin and of the pathophysiology of interstitial fibrosis suggest that treatment with epoetin may slow the progression of chronic kidney disease, both by decreasing interstitial fibrosis and by protecting against its consequences. The results of two small prospective studies and of a retrospective one also suggest that treatment with epoetin may have such protective effects.

引用

收藏

页码：S173 / S177

页数：5

相关论文

共 51 条

[1] Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway [J].

Akimoto, T ;

Kusano, E ;

Inaba, T ;

Iimura, O ;

Takahashi, H ;

Ikeda, H ;

Ito, C ;

Ando, Y ;

Ozawa, K ;

Asano, Y .

KIDNEY INTERNATIONAL, 2000, 58 (01) :269-282

[2] Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells [J].

Ashley, RA ;

Dubuque, SH ;

Dvorak, B ;

Woodward, SS ;

Williams, SK ;

Kling, PJ .

PEDIATRIC RESEARCH, 2002, 51 (04) :472-478

[3] Significance of postglomerular capillaries in the pathogenesis of chronic renal failure [J].

Bohle, A ;

MackensenHaen, S ;

Wehrmann, M .

KIDNEY & BLOOD PRESSURE RESEARCH, 1996, 19 (3-4) :191-195

[4]

Bohle A, 1996, KIDNEY INT, V49, pS2

[5]

BORDER WA, 1994, NEW ENGL J MED, V331, P1286

[6] The hyperfiltration theory: A paradigm shift in nephrology [J].

Brenner, BM ;

Lawler, EV ;

Mackenzie, HS .

KIDNEY INTERNATIONAL, 1996, 49 (06) :1774-1777

[7] Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury [J].

Brines, ML ;

Ghezzi, P ;

Keenan, S ;

Agnello, D ;

de Lanerolle, NC ;

Cerami, C ;

Itri, LM ;

Cerami, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10526-10531

[8] Effect of recombinant human erythropoietin on endothelial cell apoptosis [J].

Carlini, RG ;

Alonzo, EJ ;

Dominguez, J ;

Blanca, I ;

Weisinger, JR ;

Rothstein, M ;

Bellorin-Font, E .

KIDNEY INTERNATIONAL, 1999, 55 (02) :546-553

[9] Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury [J].

Celik, M ;

Gökmen, N ;

Erbayraktar, S ;

Akhisaroglu, M ;

Konakç, S ;

Ulukus, C ;

Genc, S ;

Genc, K ;

Sagiroglu, E ;

Cerami, A ;

Brines, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2258-2263

[10] Morphometry of interstitial fibrosis [J].

De Heer, E ;

Sijpkens, YWJ ;

Verkade, M ;

den Dulk, M ;

Langers, A ;

Schutrups, J ;

Bruijn, JA ;

van Es, LA .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 :72-73

← 1 2 3 4 5 6 →